Mateusz Kaczmarek

Mateusz Kaczmarek

Mateusz Kaczmarek is a financial and technology journalist at TS2.tech, covering stocks, artificial intelligence, semiconductors and global market developments. A graduate of the Poznań University of Economics and Business, he previously worked in financial analysis before moving into business journalism. His reporting focuses on technology companies, market trends and the forces shaping global investment markets. Follow Mateusz Kaczmarek on Google News.

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era Energy (NUAI) Stock Skyrockets on AI Data Center Pivot – Can the Rally Last?

New Era’s stock has rocketed in October thanks to its high-profile push into AI data centers. Mid-September it rebranded from New Era Helium to New Era Energy & Digital, emphasizing its shift into “energy-enabled” digital infrastructure ts2.tech. The company’s 50/50 joint venture, Texas Critical Data Centers, is designing a 438-acre AI campus in West Texas with up to 1 GW of on-site power generation. News of its progress has drawn feverish investor interest: after TCDC completed Phase One engineering in late Sept., NUAI jumped nearly 50% in one day businesswire.com, and when it announced the start of Phase Two engineering on Oct. 6, the stock surged ~85% intraday on Oct. 9 ts2.tech ts2.tech.
18 October 2025
···
MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed Stock Rockets on Breakthrough LSD Anxiety Data – Analysts Eye 100% Upside

MindMed’s stock has skyrocketed in recent weeks. After languishing in the single digits, MNMD climbed above $12 in late September and spiked to $13.09 on Oct. 14, its highest level in over a year ts2.tech marketbeat.com. The surge has pushed the stock roughly +68% year-to-date ts2.tech. Heavy trading volume accompanied the rise, as investors reacted to the latest clinical and regulatory news.
18 October 2025
·
Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

Virgin Galactic (SPCE) Stock Rockets 40% Then Reverses – What’s Fueling the Space Tourism Frenzy?

In mid-October 2025, Virgin Galactic’s stock was a top mover in the market. After languishing in the low-$3 range, SPCE shares rallied over 40% in early October on a wave of positive news ts2.tech. For example, on Oct. 16 alone the stock jumped about 6% intraday. Trading volume exploded as speculative traders piled in on hopes of new catalysts ts2.tech reuters.com. However, this enthusiasm was met by profit-taking almost immediately: by Oct. 17 the stock plunged 7.9%, erasing much of the gains and closing around $4.08 ts2.tech reuters.com. The volatile swings were driven by Virgin’s history of boom‑bust moves and heavy short interest ts2.tech ts2.tech. As TS2.tech noted, SPCE’s rollercoaster ride reflects its “high beta” nature – it “rockets upward on good news and then just as swiftly comes back to earth” ts2.tech. On Oct. 18 the Reuters market page listed SPCE at $4.08 reuters.com, far below its peaks of 2021 but still substantially above the mid-2025 lows.
18 October 2025
··
Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

Sellas Life Sciences (SLS) Stock Rallies on Promising Leukemia Data – Analysts Eye Triple-Digit Upside

As of mid-October 2025, Sellas Life Sciences trades around $2.10–2.20. This is near the top of its 52-week range and about twice its price at the start of 2025 stockanalysis.com marketbeat.com. Trading volume and volatility have picked up – for instance, on Oct. 14 a massive spike in call-option activity coincided with bullish sentiment marketbeat.com. The stock’s YTD gain far outpaces many small-cap biotechs. Technical platforms note SLS is in “uptrend” territory: the stock is well above its 20-day EMA and 50-day EMA tipranks.com, which TipRanks flags as “Buy” signals. Meanwhile, about 18% of shares are sold short marketbeat.com, a high level that could fuel further swings if any surprise news hits.
18 October 2025
··
Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s $9B Chinese Fighter Jet Deal Shocks the World

Indonesia’s abrupt pivot to Chinese fighters has captured global attention. Defense analysts say it underscores Jakarta’s insistence on strategic autonomy. “Foreign actors can spread disinformation, but at the end of the day, Indonesia buys what it chooses,” writes analyst Muhammad Zulfikar Rakhmat asiatimes.com. In practice, Jakarta is “quietly demonstrating that strategic autonomy is possible” – fielding the latest jets from East and West while balancing great-power pressures asiatimes.com. For now, Southeast Asian neighbors and global arms makers will be watching closely how this deal unfolds and how it reshapes the region’s airpower balance.
18 October 2025
···
Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics (RANI) Stock Surges 150% on $1B+ Chugai Collaboration – Analysts Weigh In

Rani Therapeutics, a clinical-stage biotech developing the RaniPill® capsule for oral delivery of biologic drugs, was essentially flat around $0.45–$0.50 from mid-September through early October. On Oct. 17, it announced a collaboration with Chugai to turn one of Chugai’s injectable rare-disease antibodies into a pill formulation. The news, coupled with the new funding, ignited a buying frenzy ts2.tech. By mid-day Friday, RANI was up ~180% on the session ts2.tech, markedly outpacing the broader market’s modest gains.
18 October 2025
···
Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat Stock Implodes: 60% Crash After Shocking Debt-For-Equity Swap

Beyond Meat’s brand remains visible to consumers, but behind the scenes its finances are in crisis. In mid-October 2025 the company announced an early settlement of its convertible debt exchange offer, triggering a historic market reaction. As Reuters reports, BYND shareholders are “agonizing” after the company offered existing bondholders new debt and stock in place of their $1.1 billion 2027 notes reuters.com globenewswire.com. With ~96.9% of noteholders participating, Beyond Meat will issue about $196.2 M in new 7.0% convertible notes plus a $12.5 M tender premium – roughly $208.7 M total – and 316.15 million new shares globenewswire.com globenewswire.com. In other words, each current share will face massive dilution.
18 October 2025
·
Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy (LBRT) Stock Surges 28% After Q3 Earnings – What’s Next?

Liberty Energy’s logo has been in the spotlight as the stock rallied on the latest earnings. On October 17, one day after Liberty’s Q3 report, the stock soared ~28% intraday, closing at $15.32 reuters.com ts2.tech. That move came even though broader markets were relatively calm. Traders piled in on the “better-than-feared” outcome. By contrast, LBRT’s shares had been drifting lower for months; at one point earlier in Oct they were down over 40% on the year ts2.tech.
18 October 2025
···
Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

Gilead Stock Skyrockets on Patent Win and Game-Changing HIV Therapies

In summary, Gilead’s share price has rallied on a wave of HIV-related breakthroughs, pipeline achievements, and upbeat guidance. With third-quarter results due Oct. 30, investors will be watching for sustained growth. For now, analysts remain generally optimistic: the consensus rating is “Buy” based on Gilead’s diversified portfolio and innovation investing.com ts2.tech. As management shifts into high gear on oncology and global health programs, the long-term outlook is that Gilead’s multiple drivers will more than offset sector risks.
18 October 2025
·
Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold Mania 2025: Record Rally Shatters Records – $5,000 in Sight?

Gold prices have soared this October, breaching $4,300/oz for the first time ever and up over 60% year-to-date reuters.com reuters.com. The safe-haven rally is driven by Fed rate-cut expectations, US political uncertainty and global tensions economictimes.indiatimes.com reuters.com. Analysts note no clear end to the rally: Metals Focus’s Matthew Piggott targets ~$5,000/oz absent a “major shift” ts2.tech, and HSBC now sees gold averaging near $5,000 by 2026 reuters.com reuters.com. In Asia, Diwali/Dhanteras festival buying has pushed Indian premiums to decade highs reuters.com, with domestic prices at ~₹1,31,700 per 10g reuters.com. Bullion flows are “insatiable” – record ETF inflows and heavy central bank buying underpin the surge ts2.tech reuters.com. Even silver joined the run – hitting a record ~$54.47/oz in mid-October reuters.com. Meanwhile US stocks ticked up as gold paused reuters.com, reflecting eased bank-credit worries and trade jitters.
18 October 2025
··
Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Weight-Loss Drug Mania Shook Markets—Now Hims & Hers Bets on a Menopause Care Boom

Hims & Hers’ expansion into menopause care was greeted with enthusiasm in the market. On October 15, the San Francisco–based telehealth provider announced it is now offering affordable treatment plans for women in perimenopause and menopause via its Hers platform businesswire.com businesswire.com. The move adds a new specialty to Hers, which already serves over 500,000 women subscribers businesswire.com. By connecting patients with providers trained in menopause care, Hims & Hers aims to fill a long-neglected gap in women’s health. “Women have been navigating an outdated healthcare system that wasn’t designed for them for too long. Hers was built to serve every woman on her terms,” said Dr. Jessica Shepherd, Chief Medical Officer of Hims & Hers businesswire.com businesswire.com. She noted that the goal is “building a platform that women can trust to access the care they need,” by increasing access to specialists for every life stage businesswire.com.
17 October 2025
·
Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial Stock Surges on Strong Q3 Profit; Analysts Upbeat on Outlook

Regions Financial’s stock has seen whipsaw volatility in recent days. Last week’s renewed banking sector fears – sparked by a $50 million fraud-related loan loss at Zions Bancorp and other credit worries – hit regional bank stocks hard, sending the KBW Regional Banking Index down over 6% on Oct. 16 ts2.tech. Regions was caught in that downdraft, with RF shares plunging about 5–6% on Thursday to close around $23.33 marketbeat.com, a multi-month low.
17 October 2025
··
VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX Stock Soars 71% on Major Government Contract – What’s Next for VHC?

VirnetX shocked the market with an eye-popping rally on October 17, 2025, after unveiling a significant government deal. The Nevada-based cybersecurity firm announced it won a General Services Administration Multiple Award Schedule contract late Thursday, and by Friday’s open the stock exploded upward stocktwits.com. Shares opened 71% higher and briefly touched a level not seen in over two years stocktwits.com. The exuberance was directly tied to the GSA news, which investors interpreted as a game-changer for VirnetX’s federal business prospects.
17 October 2025
··
Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Stock Surges on Bitcoin Treasury Strategy and Expansion Plans

Harrison Global Holdings shares jumped about 11–12% on Oct 17, 2025, trading near $0.22 google.com. A pre-market report noted a ~19% spike to $0.23 after hours gurufocus.com. - The company announced on Oct 17 a binding term sheet with White Lion Capital to execute a Bitcoin Purchase Agreement, formally launching a “Bitcoin Treasury Strategy” marketwirenews.com. Harrison says this is meant to diversify its cash reserves and hedge inflation marketwirenews.com. - Investor Sentiment: Technical indicators are mixed. GuruFocus notes BLMZ’s RSI is around 47 and its annualized volatility is very high gurufocus.com gurufocus.com. An AI-based model rates the stock a “Strong Buy”, citing 5 buy vs. 3 sell technical signals, and projects a ~3.5% gain over the next month intellectia.ai intellectia.ai. - Business Expansion: Earlier this week, Harrison unveiled plans to establish a ¥10 billion fund with European partners to promote Korean and Japanese media content in Europe and South America marketwirenews.com. Co-CEO Ryoshin Nakade said the collaboration “will significantly contribute to the expansion of excellent media content … into Europe and South America” marketwirenews.com. On Sept. 19 the company detailed strategic moves including investments in Asian content and biotech marketwirenews.com. - Stock Forecasts: No Wall Street analysts cover BLMZ, but
17 October 2025
··
Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences Skyrockets on FDA Boost – Is This Nicotine Addiction Breakthrough a Game Changer?

Achieve Life Sciences stock exploded higher on the FDA news, reflecting growing optimism around cytisinicline’s prospects. In pre-market trading on Oct. 17, ACHV jumped about 22.7% after the company revealed it received a rare FDA Commissioner’s National Priority Voucher for cytisinicline’s vaping cessation indication investing.com. This rally propelled the shares to multi-month highs in the mid-$3 range. Earlier in the week, ACHV had already begun gaining momentum – on Oct. 15 the stock broke above its 200-day moving average and hit $3.19 marketbeat.com, a bullish technical signal. As of Thursday’s close, the stock was at $3.08, up roughly 10% over the past month and far outperforming the broader market investing.com.
17 October 2025
··
Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

Huntington Bancshares’ Profit Surge Defies Banking Jitters – HBAN Stock Eyes Rebound

HBAN shares are attempting a comeback after a volatile week. On October 16, Huntington’s stock slid 5.2% to $15.37 markets.financialcontent.com amid a broader rout in regional bank stocks. Credit jitters hit the sector after a “cockroach” of bad loan news – one mid-sized lender disclosed a fraud-linked loss and another flagged sour commercial loans ts2.tech ts2.tech. The KBW Regional Bank Index plunged ~6.5% that day ts2.tech, dragging down even healthy banks like Huntington.
17 October 2025
·
Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Ally Financial Stock Soars on Profit Surge – Analysts Bullish on What’s Next

Ally Financial delivered an upside surprise in Q3 2025, powering a relief rally in its stock. The Detroit-based digital bank – a major auto lender and online banking provider – reported third-quarter earnings on October 17 that handily beat expectations. Net income more than doubled year-over-year, rising to $371 million versus $171 million in Q3 2024 nasdaq.com. On an adjusted basis, earnings were $1.15 per share, about 14% above analyst consensus of ~$1.01 chartmill.com. Revenue came in at $2.17 billion, up ~3% from a year ago and slightly ahead of forecasts around $2.11B chartmill.com.
17 October 2025
·
Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Biotech Breakthrough: Rani Therapeutics (RANI) Stock Skyrockets on $1B Deal – What Investors Need to Know

Rani Therapeutics’ stock price skyrocketed on Friday, Oct. 17, after the company unveiled a major partnership and funding news. In pre-market trade, RANI jumped about 150% and continued to rally after the market open tipranks.com. The stock, which had closed at just $0.47 the prior day, briefly hit approximately $1.37 per share – nearly a 3× gain in value google.com. By midday, shares were still trading around the $1.30 level, up almost +180% on the day. This stunning one-day move snapped RANI out of penny-stock territory and back above the Nasdaq’s $1 minimum bid price, easing near-term delisting fears.
17 October 2025
···
Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s Stock Jumps on Earnings Beat and Mega-Merger – Is FITB a Buy Now?

Fifth Third’s stock is bouncing back to end a volatile week. By midday Friday, FITB shares were trading around $41–$42, up roughly 2–3% after the bank’s strong earnings report beat expectations reuters.com. The mini-rally follows a sharp selloff in regional bank stocks just one day earlier: on Thursday, Fifth Third fell about 4% as part of a broader rout fueled by credit worries ts2.tech. News of surprise loan losses at two peer banks – Zions and Western Alliance – had spooked investors, dragging the KBW regional banking index down over 6% in its worst drop since April ts2.tech ts2.tech.
17 October 2025
····
SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB Stock Q3 Beat, $4B Buybacks & Oil Swoon: Will Schlumberger (SLB) Rebound?

SLB’s third-quarter 2025 results, released on Oct 17, showed better-than-expected profitability even as industry conditions softened. The company earned $0.69 per share for Q3, topping estimates of $0.66 Tipranks. Revenue came in at $8.93 billion, essentially on target Tipranks. Both metrics were down modestly from a year ago as global drilling activity has cooled. CEO Olivier Le Peuch described the quarter as “resilient,” noting SLB expanded its EBITDA margins and generated $1.8 B in free cash flow, thanks to efficiency gains Investing Investing. North America proved a bright spot – revenue there rose +14% YoY to $1.93 B as the U.S. rig count stabilized Reuters Reuters. International revenue fell 7% YoY to $6.92 B amid lower spending in regions like Latin America and Europe Reuters. Le Peuch noted that high oil inventories and geopolitical uncertainties made overseas customers cautious on short-cycle projects Investing Investing.
17 October 2025
···
1 … 106 107 108 109 110 … 173
Follow on Google News
Add as preferred source Open in Google News
AI PORTFOLIO

Top Stock Picks

Today’s highest-ranked model selections.

#1 STRONG BUY

AerCap

NYSE: AER 95 / 100
#2 BUY

Uber

NYSE: UBER 93 / 100
#3 BUY ON WEAKNESS

Taiwan Semiconductor

NYSE: TSM 91 / 100
#4 TACTICAL BUY

dLocal

NASDAQ: DLO 88 / 100
#5 BUY THE RESET

Tapestry

NYSE: TPR 86 / 100
View full portfolio
Editorial model selection. Not personalised advice.